Literature DB >> 9706742

Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis.

W E Samlowski1, C Y Yim, J R McGregor.   

Abstract

Nitric oxide synthesis is strongly induced during IL-2 treatment of mice and humans. While this free radical can act as an antitumor mechanism by inhibiting cellular respiration and DNA synthesis in cancer cells, immunosuppressive effects have also been suggested. We evaluated the effects of NO exposure on the induction of murine lymphokine-activated killer (LAK) cells from splenocytes by IL-2 (6000 IU/ml). When splenocytes were exposed to pure NO gas for 30 min prior to the addition of IL-2, complete abrogation of LAK cell cytotoxicity was observed. In contrast, cytolytic activity of already activated LAK cells was only minimally affected by NO exposure. NO exposure markedly depressed cellular proliferation in response to concanavalin A or IL-2. Immunostaining of LAK cell cultures following NO exposure revealed a marked decrease in CD8+, and peanut lectin (PNA+)/CD56+ subsets (48 and 69%). Dual staining of LAK cells for DNA strand breaks and either PNA or CD8+ identified the induction of programmed cell death in these subsets 12-24 h following NO exposure. These experiments demonstrate that NO has the capacity to inhibit LAK cell induction by inducing apoptosis of cytolytic lymphocyte precursors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706742     DOI: 10.1006/niox.1998.0169

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  2 in total

1.  Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells.

Authors:  Marcella Ferlito; Kaikobad Irani; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

2.  Antisteroidogenic action of nitric oxide on human corpus luteum in vitro: mechanism of action.

Authors:  M C Johnson; H A Diaz; C Stocco; A Palomino; L Devoto; M Vega
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.